CORT FY 2021 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$366M+3.4% YoY

Gross Profit

$361M98.6% margin

Operating Income

$124M34.0% margin

Net Income

$113M30.7% margin

EPS (Diluted)

$0.89

Cash Flow

Operating Cash Flow

$168M

Free Cash Flow

$167M

Stock-Based Comp.

$43M

Balance Sheet

Total Assets

$424M

Total Liabilities

$48M

Stockholders' Equity

$376M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$366M	$354M	+3.4%
Gross Profit	$361M	$348M	+3.6%
Operating Income	$124M	$128M	-2.9%
Net Income	$113M	$106M	+6.1%